AzTrials
AzTrials

HemorrhoidsNCT06132152

Hemorrhoids: Options of Traditional Hemorrhoidectomy

A study testing Open hemorrhoidectomy with 'cold' scalpel and Open hemorrhoidectomy with electrosurgical scalpel in people with Hemorrhoids and Open Hemorrhoidectomy, run by Center of Endourology "Endocenter" at 1 site in Russia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this prospective clinical trial is to compare the outcomes of several technical options of open hemorrhoidectomy in patients with symptomatic hemorrhoids. Randomly allocated participants will undergo surgical treatment for hemorrhoids with one technical option of open hemorrhoidecomy: with 'cold' scalpel… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hemorrhoids, Open Hemorrhoidectomy
What is being tested?
Open hemorrhoidectomy with 'cold' scalpel and Open hemorrhoidectomy with electrosurgical scalpel
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteRussia
Study dates
1 Dec 2023to 1 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients over 18 years old
  • Diagnosed symptomatic hemorrhoidal disease
  • Planned surgery - open hemorrhoidectomy
  • Absence of other anarectal diseases
  • I, II class of anesthetic risk according to ASA classification
  • Voluntary signing by the participant of an informed consent for surgical treatment and participation in a clinical trial.

Who cannot join

  • Chronic or prolonged use of medications, including narcotic drugs, with analgesic effect for other diseases.
  • Patients who have contraindications or technical impossibility of performing subarachnoid anesthesia or the full standard volume of surgery for the corresponding disease.
  • Patients who refused to participate at any time before the end of the study, as well as patients who did not pass the final postoperative monitoring (1 month after the intervention).
  • Pregnant women
  • Complicated course of the postoperative period due to exacerbation of concomitant diseases

Trial locations and contacts

1 site in 1 country.

Tatiana Garmanova, PhD contact

+79773429249

tatianagarmanova@gmail.com

Ekaterina Kazachenko, MD contact

+79269721922

ekaterina.k.97@mail.ru

Russia1 site
  • Surgical department of the Medical Research and Educational Center of Lomonosov Moscow State University

    Moscow, 119991

    Tatiana Garmanova, PhD, +79773429249, tatianagarmanova@gmail.com

    Ekaterina Kazachenko, MD, +79269721922, ekaterina.k.97@mail.ru

Other trials in Russia

About this study

Official title: Evaluation of Hemorrhoidectomy Techniques: Scalpel and Electrosurgery

The goal of this prospective clinical trial is to compare the outcomes of several technical options of open hemorrhoidectomy in patients with symptomatic hemorrhoids. Randomly allocated participants will undergo surgical treatment for hemorrhoids with one technical option of open hemorrhoidecomy: with 'cold' scalpel or electrosurgical instruments. All information to evaluate outcomes between the groups will be collected before surgery and 1 week and 30 days after surgery.

Read the detailed description

This is a single-center prospective randomized controlled study will be conducted on the basis of the surgical department. Patients with symptomatic hemorrhoids and who will be intended for surgical treatment (open hemorrhoidectomy) will be randomly allocated to one of the group. Prior to surgery the demographic and clinical data will be collected. Open hemorrhoidectomy under spinal anesthesia will be performed with one of the technical options according to the patient's group:

  • hemorrhoidectomy with 'cold' scalpel for cutting the perianal skin and anal mucose
  • hemorrhoidectomy with electrosurgical scalpel for cutting the perianal skin and anal mucose.

Intraoperative and postoperative data will be collected during first week after surgery and 30 days after surgery. Then the primary and secondary outcomes are evaluated between the groups.

Being tested
Open hemorrhoidectomy with 'cold' scalpel, Open hemorrhoidectomy with electrosurgical scalpel
Keywords
symptomatic hemorrhoids, open hemorrhoidectomy, postoperative pain, electrosurgery
Medical subject headings
Hemorrhoids, Pain, Postoperative, Hyperthermia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Open hemorrhoidectomy with 'cold' scalpelProcedure or surgery

    Open hemorrhoidectomy will be performed in traditional way, including radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. 'Cold' scalpel will be used for cutting the perianal skin and anal mucose. To stop and prevent bleeding the monopolar coagulation may be used but on low energy level and with no touching the skin and mucose.

  • Open hemorrhoidectomy with electrosurgical scalpelProcedure or surgery

    Open hemorrhoidectomy will be performed in traditional way, including radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. Electrosurgical scalpel will be used during all steps including cutting the perianal skin and anal mucose and to stop and prevent bleeding.

Study groups in NCT06132152
Study groupRoleWhat they receive
Open hemorrhoidectomy with 'cold' scalpelActive comparatorOpen hemorrhoidectomy will be performed in traditional way, including radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. 'Cold' scalpel will be used for cutting the perianal skin and anal mucose. To stop and prevent bleeding the monopolar coagulation may be used but on low energy level and with no touching the skin and mucose.
Receives: Procedure: Open hemorrhoidectomy with 'cold' scalpel
Open hemorrhoidectomy with electrosurgical scalpelActive comparatorOpen hemorrhoidectomy will be performed in traditional way, including radial skin-mucosal excision of enlarged hemorrhoids with ligation of the vascular pedicle. Electrosurgical scalpel will be used during all steps including cutting the perianal skin and anal mucose and to stop and prevent bleeding.
Receives: Procedure: Open hemorrhoidectomy with electrosurgical scalpel

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain at rest and during defecation

    The pain was assessed using a visual analogue scale (VAS uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end)

    Measured: during 10 days after surgery

Secondary outcomes (6)
  1. Rate of prescribing opioid analgesics

    the rate of prescribing opioid analgesics to prevent the pain from rising above VAS 5 after surgery (VAS uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end)

    Measured: 3 days after surgery

  2. Other medications use

    The frequency of other analgesics taken

    Measured: 10 days after surgery

  3. Readmission rate

    The number of cases of repeated appeals for relapse of the disease or hospitalizations

    Measured: 30 days after surgery

  4. The life quality rate

    The overall quality of life was assessed using the EQ-5D patient questionnaire. The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems.

    Measured: 7 and 30 days

  5. Complication rate

    Cases of bleeding, urinary retention, infectious complications after surgery

    Measured: within 30 days after surgery

  6. Residual symptoms

    The presence of residual symptoms after surgery

    Measured: 30 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2023
  2. Study start1 Dec 2023 (estimated)
  3. Primary completion1 May 2024 (estimated)
  4. Study completion1 Nov 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
In case of meeting inclusion criteria of patient the selection of the group will be determined by randomization, so both groups will be recruited simultaneously
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06132152
Sponsor's protocol ID
59954654
Status last verified
Nov 2023
First submitted
5 Nov 2023
Last updated
15 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Open hemorrhoidectomy with 'cold' scalpel and Open hemorrhoidectomy with electrosurgical scalpel in people with Hemorrhoids and Open Hemorrhoidectomy, run by Center of Endourology "Endocenter" at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tatiana Garmanova, PhD (+79773429249, tatianagarmanova@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain at rest and during defecation (time frame: during 10 days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in